Investment analysts at Lifesci Capital started coverage on shares of Protara Therapeutics (NASDAQ:TARA – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat ...

Fintel reports that on March 11, 2025, LifeSci Capital initiated coverage of Protara Therapeutics (NasdaqGM:TARA) with a ...

Explore Protara Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TARA. Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor ...

Infimobile has officially launched in the U.S., delivering affordable, high-quality mobile wireless plans with nationwide ...

GREAT FALLS — Food prices are expected to go up 3.4% in 2025, according to the USDA. The increase in food prices is ...

Brackets may change. The standard deduction could fall. And President Trump will probably not remove taxes on Social Security ...

Investment analysts at HC Wainwright lifted their Q1 2025 earnings per share estimates for shares of Protara Therapeutics in ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Prices at thrift stores are rising, forcing people to buy less and look elsewhere to meet their needs. But operators face ...

President Trump sent markets into another tailspin by announcing additional tariffs on Canada, suggesting a falling stock ...

TD Cowen analyst Tara Bancroft maintained a Buy rating on Vaxcyte (PCVX – Research Report) today and set a price target of $135.00.Discover the ...